Literature DB >> 14142092

'DAUNOMYCIN', A NEW ANTIBIOTIC OF THE RHODOMYCIN GROUP.

A DIMARCO, M GAETANI, P OREZZI, B M SCARPINATO, R SILVESTRINI, M SOLDATI, T DASDIA, L VALENTINI.   

Abstract

Entities:  

Keywords:  ANTIBIOTICS; ANTIMETABOLITES; ANTINEOPLASTIC AGENTS; CARCINOMA, EHRLICH TUMOR; DAUNOMYCIN; DNA, NEOPLASM; EXPERIMENTAL LAB STUDY; GLYCOSIDES; HEPATOMA; MICE; PHARMACOLOGY; POLAROGRAPHY; RATS; RNA, NEOPLASM; ULTRAVIOLET RAYS

Mesh：

Substances：

Year:  1964        PMID： 14142092     DOI： 10.1038/201706a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  28 in total

1.  Isolation and characterization of a gene from Streptomyces sp. strain C5 that confers the ability to convert daunomycin to doxorubicin on Streptomyces lividans TK24.

Authors:  M L Dickens; W R Strohl
Journal:  J Bacteriol       Date:  1996-06       Impact factor: 3.490

Review 2.  A comprehensive review of glycosylated bacterial natural products.

Authors:  Sherif I Elshahawi; Khaled A Shaaban; Madan K Kharel; Jon S Thorson
Journal:  Chem Soc Rev       Date:  2015-11-07       Impact factor: 54.564

3.  Functional AdoMet Isosteres Resistant to Classical AdoMet Degradation Pathways.

Authors:  Tyler D Huber; Fengbin Wang; Shanteri Singh; Brooke R Johnson; Jianjun Zhang; Manjula Sunkara; Steven G Van Lanen; Andrew J Morris; George N Phillips; Jon S Thorson
Journal:  ACS Chem Biol       Date:  2016-07-14       Impact factor: 5.100

Review 4.  Streptomycetes producing daunomycin and related compounds: do we know enough about them after 25 years?

Authors:  J Huk; M Blumauerova
Journal:  Folia Microbiol (Praha)       Date:  1989       Impact factor: 2.099

Review 5.  Antineoplastic and immunosuppressive drugs. I. Biochemical and clinical pharmacological considerations.

Authors:  A H Chalmers; L A Burgoyne; A W Murray
Journal:  Drugs       Date:  1972       Impact factor: 9.546

6.  Studies on the process of mouse meiosis and ovulation with daunomycin.

Authors:  G M Jagiello; J S Lin
Journal:  Experientia       Date:  1973-05-01

7.  Differential interaction of nogalamycin with DNA of varying base composition.

Authors:  B K Bhuyan; C G Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1965-08       Impact factor: 11.205

8.  AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group.

Authors:  Linlin Zhong; Honglin Shen; Chenfei Huang; Hongwu Jing; Deliang Cao
Journal:  Toxicol Appl Pharmacol       Date:  2011-05-26       Impact factor: 4.219

Review 9.  Fibrates in the chemical action of daunorubicin.

Authors:  Ganesaratnam K Balendiran
Journal:  Curr Cancer Drug Targets       Date:  2009-05       Impact factor: 3.428

10.  Synthesis and DNA-binding affinity studies of glycosylated intercalators designed as functional mimics of the anthracycline antibiotics.

Authors:  Wei Shi; Robert S Coleman; Todd L Lowary
Journal:  Org Biomol Chem       Date:  2009-07-17       Impact factor: 3.876
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.